Sodium valproate and 5-aza-2′-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells

The Mood Stabilizers Valproic Acid and Lithium Enhance Mesenchymal Stem Cell Migration via Distinct Mechanisms

TET protein inhibitors: Potential and limitations - ScienceDirect

Valproate-Induced Epigenetic Upregulation of Hypothalamic Fto Expression Potentially Linked with Weight Gain

Valproic acid influences the expression of genes implicated with hyperglycaemia-induced complement and coagulation pathways

Mechanism of Sodium Valproate Combined with Decitabine in Inhibiting Hepatocellular Carcinoma Cells Epithelial-Mesenchymal Transition and Invasion and Metastasis Based on p38 Mitogen-Activated Protein Kinases/Heat Shock Protein 27 Regulating

Sodium valproate (VPA) interactions with DNA and histones - ScienceDirect

Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion

Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer

Combination treatment with DAC and Pano enhanced reactivation of

Diminished effects of 5-aza-dC (Aza) in TET1-depleted HCT116 cells. (A)

Sodium valproate and 5-aza-2′-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells

Demethylation is observed in a subset of the 131 CpG probes originally

Cytometric assessment of CD133− and CD133+ and their cell cycle in